0
Screening Datapoints
Menu
Vivtex’s proprietary platform enables for the first time the use of intact gastrointestinal tract tissue for fully automated robotic testing. We use this technology to enable the development of new drugs that can be given orally instead of painful and inconvenient needle injections.
Vivtex’sproprietaryplatform enables for the first time the use of intact gastrointestinal tract tissue for fully automated robotic testing. We use this technology to enable the development of new drugs that can be given orally instead of painful and inconvenient needle injections.
Screening Datapoints
APIs tested
Lead Formulations Identified
Biotech/Pharma Partnerships
From Robert Langer - Vivtex’s founder and our Chairman of the Board.
We create next generation oral therapeutics by partnering with the leading Pharma and Biotech Companies.
Through our robotic screening technology and AI capabilities we identify new oral drug delivery systems and drug candidates with maximal GI absorption to avoid needle administration.
790 Memorial Drive Suite 300, Cambridge, MA 02139 | Wagistrasse 13, 8952 Schlieren, Switzerland